8 ud af 8 tidsskrifter valgt, ingen søgeord valgt, emner højest 7 dage gamle, sorteret efter nyeste først.
31 emner vises.
1
Communicable disease threats report, 21–27 April 2024, week 17
ECDC
ECDC Communicable Disease Threats Report, 27.04.2024
Tilføjet 27.04.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21–27 April 2024 and includes updates on respiratory virus epidemiology in the EU/EEA, West Nile virus, SARS-CoV-2 variant classification and Cholera.
Læs mere
2
New Contraindications to Coadministration of Atazanavir
Medscape Infectious Diseases, 26.04.2024
Tilføjet 26.04.2024
New restrictions have been imposed by the European Medicines Agency on the coadministration of the anti-HIV drug atazanavir with a variety of other agents. Medscape Medical News
Læs mere
3
Two Biosimilars Approved in Europe for Autoimmune Disorders
Medscape Infectious Diseases, 26.04.2024
Tilføjet 26.04.2024
The drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn\'s disease. Medscape Medical News
Læs mere
4
Communicable disease threats report, 21–27 April 2024, week 17
ECDC
ECDC COVID-19 updates, 26.04.2024
Tilføjet 26.04.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21–27 April 2024 and includes updates on respiratory virus epidemiology in the EU/EEA, West Nile virus, SARS-CoV-2 variant classification and Cholera.
Læs mere
5
Weekly respiratory virus update, week 16, April 2024
ECDC
ECDC COVID-19 updates, 26.04.2024
Tilføjet 26.04.2024
Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
Læs mere
6
Europe Strengthens Future Disease Defense
Medscape Infectious Diseases, 26.04.2024
Tilføjet 26.04.2024
A network of countries and health agencies will coordinate a strategy to identify and mitigate future disease threats. Medscape Medical News
Læs mere
7
MASLD Plus HIV Ups Risk for CVD But Not Liver Disease
Medscape Infectious Diseases, 26.04.2024
Tilføjet 26.04.2024
A large study reveals an increased risk for adverse cardiovascular events but not for liver disease progression in adults with MASLD disease and HIV infection. Medscape Medical News
Læs mere
8
Scenarios of future mpox outbreaks among men who have sex with men: a modelling study based on cross-sectional seroprevalence data from the Netherlands, 2022
Marc C Shamier, Luca M Zaeck, Hannelore M Götz, Bruno Vieyra, Babs E Verstrepen, Koen Wijnans, Matthijs RA Welkers, Elske Hoornenborg, Brigitte AGL van Cleef, Martin E van Royen, Kai J Jonas, Marion PG Koopmans, Rory D de Vries, David AMC van de Vijver and Corine H GeurtsvanKessel
Eurosurveillance latest updates, 26.04.2024
Tilføjet 26.04.2024
Background Following the 2022–2023 mpox outbreak, crucial knowledge gaps exist regarding orthopoxvirus-specific immunity in risk groups and its impact on future outbreaks. Aim We combined cross-sectional seroprevalence studies in two cities in the Netherlands with mathematical modelling to evaluate scenarios of future mpox outbreaks among men who have sex with men (MSM). Methods Serum samples were obtained from 1,065 MSM attending Centres for Sexual Health (CSH) in Rotterdam or Amsterdam following the peak of the Dutch mpox outbreak and the introduction of vaccination. For MSM visiting the Rotterdam CSH, sera were linked to epidemiological and vaccination data. An in-house developed ELISA was used to detect vaccinia virus (VACV)-specific IgG. These observations were combined with published data on serial interval and vaccine effectiveness to inform a stochastic transmission model that estimates the risk of future mpox outbreaks. Results The seroprevalence of VACV-specific antibodies was 45.4% and 47.1% in Rotterdam and Amsterdam, respectively. Transmission modelling showed that the impact of risk group vaccination on the original outbreak was likely small. However, assuming different scenarios, the number of mpox cases in a future outbreak would be markedly reduced because of vaccination. Simultaneously, the current level of immunity alone may not prevent future outbreaks. Maintaining a short time-to-diagnosis is a key component of any strategy to prevent new outbreaks. Conclusion Our findings indicate a reduced likelihood of large future mpox outbreaks among MSM in the Netherlands under current conditions, but emphasise the importance of maintaining population immunity, diagnostic capacities and disease awareness.
Læs mere
9
Outbreak of invasive Group A streptococcus disease in a nursing home in Ireland in February 2023 caused by emm type 18
Ciara Carroll, Mary Meehan, Roisin Connolly, Jayne Prendergast, Colette Magnone, Aine Meehan, Chantal Migone, Keith Ian Quintyne, Caroline Carpenter, Helen Byrne, Robert Cunney and Paul Mullane
Eurosurveillance latest updates, 26.04.2024
Tilføjet 26.04.2024
An out-of-season increase in cases of invasive Group A streptococcus (iGAS) was observed in Ireland between October 2022 and August 2023. We describe the management of an iGAS outbreak involving three nursing home residents in Ireland in early 2023. A regional Department of Public Health was notified of an iGAS case in a nursing home resident in January 2023. When two further cases among residents were notified 7 days later, an outbreak was declared. Surveillance for GAS/iGAS infection in residents and staff was undertaken. The site was visited to provide infection prevention and control (IPC) support. Isolates were emm typed. A total of 38 residents and 29 staff in contact with resident cases were provided with antibiotic chemoprophylaxis. Seven additional staff with no direct resident contact also received chemoprophylaxis after finding one probable localised GAS infection among them. No more iGAS cases subsequently occurred.Site visit recommendations included advice on terminal cleaning and cleaning of shared equipment, as well as strengthening staff education on hand hygiene and masking. All isolates were of emm subtype 18.12, a subtype not previously detected in Ireland. Key outbreak control measures were rapid delivery of IPC support and chemoprophylaxis. Emm18 is infrequently associated with GAS infections.
Læs mere
10
Severe A(H1N1)pdm09 influenza acute encephalopathy outbreak in children in Tuscany, Italy, December 2023 to January 2024
Luca Bartolini, Silvia Ricci, Chiara Azzari, Maria Moriondo, Francesco Nieddu, Manuela L’Erario, Zaccaria Ricci, Gabriele Simonini, Marzia Mortilla, Giuseppe Indolfi, Carlotta Montagnani, Elena Chiappini, Luisa Galli and Renzo Guerrini
Eurosurveillance latest updates, 26.04.2024
Tilføjet 26.04.2024
A severe outbreak of influenza A(H1N1pdm09) infection in seven children (median age: 52 months) occurred between December 2023 and January 2024 in Tuscany, Italy. Clinical presentation ranged from milder encephalopathy to acute necrotizing encephalopathy (ANE) with coma and multiorgan failure; one child died. This report raises awareness for clinicians to identify and treat early acute encephalopathy caused by H1N1 influenza and serves as a reminder of severe presentations of influenza in young children and the importance of vaccination.
Læs mere
11
Availability of drugs for the treatment of multidrug-resistant/rifampicin-resistant tuberculosis in the World Health Organization European Region, October 2023
Ralf Otto-Knapp, Suzanne Edwards, Giorgi Kuchukhidze, Stefan Kröger, Brit Häcker, Stela Bivol and Askar Yedilbayev
Eurosurveillance latest updates, 26.04.2024
Tilføjet 26.04.2024
The BPaLM regimen (bedaquiline, pretomanid, linezolid and moxifloxacin) recently recommended by the World Health Organization offers short, safe, and effective treatment for multidrug-resistant/rifampicin-resistant tuberculosis (TB). In a survey with national TB focal points in 18 central and western European countries to explore barriers for the implementation of BPaLM, only three reported full availability of pretomanid, a necessary component of this regimen. Implementation barriers included financing and procurement. Solutions on national and supranational level are needed to guarantee universal access.
Læs mere
12
Contact tracing management of a measles case in a paediatric hospital: experience of the local public health unit, Portugal, January 2024
Daniel Saldanha Resendes, António Tomás, Mariana Pinção Cardoso, Sebastian von Schreeb, Rita Miranda Ferrão, Paula Vasconcelos, Maria Helena Almeida, Bruno Novo Castro, Vasco Ricoca Peixoto, Renato Lourenço Silva and Margarida de Morais
Eurosurveillance latest updates, 26.04.2024
Tilføjet 26.04.2024
In January 2024, a child was diagnosed with measles in a paediatric hospital in Lisbon. Of 123 contacts, 39 (32%) were not fully immunised, presenting a risk for a potential outbreak. The public health unit initiated control measures and identified challenges during the response, such as the lack of interoperability between information systems and accessing vaccination records. The lessons learned prompted changes to national contact tracing procedures for measles, further strengthening Portugal’s preparedness.
Læs mere
13
Authors’ correction for Euro Surveill. 2024;29(16)
Eurosurveillance editorial team
Eurosurveillance latest updates, 26.04.2024
Tilføjet 26.04.2024
14
QuickStats: Percentage of Employed Adults Aged ≥18 Years Who Slept 7 Hours per 24-Hour Period, by Sex and Number of Work Hours per Week - United States, 2022
Morbidity and Mortality Weekly Report (MMWR), 26.04.2024
Tilføjet 26.04.2024
This report describes the percentage of employed adults who slept less than seven hours per 24-hour period.
Læs mere
15
Notes from the Field: Group A Streptococcus Bacteremia in Persons Who Inject Drugs - Northern Vermont, January 2020-October 2023
Morbidity and Mortality Weekly Report (MMWR), 26.04.2024
Tilføjet 26.04.2024
This report describes an increase in group A streptococcal infections among people who inject drugs in Vermont.
Læs mere
16
Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024
Morbidity and Mortality Weekly Report (MMWR), 26.04.2024
Tilføjet 26.04.2024
This report describes a recommendation from the Advisory Committee on Immunization Practices that all people ages ≥65 years and older receive one additional dose of any updated (2023-2024 Formula) COVID-19 vaccine.
Læs mere
17
Investigation of Presumptive HIV Transmission Associated with Receipt of Platelet-Rich Plasma Microneedling Facials at a Spa Among Former Spa Clients - New Mexico, 2018-2023
Morbidity and Mortality Weekly Report (MMWR), 26.04.2024
Tilføjet 26.04.2024
This report describes an investigation of multiple HIV infections among people who received microneedling facials.
Læs mere
18
SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance - Respiratory Virus Transmission Network, November 2022-May 2023
Morbidity and Mortality Weekly Report (MMWR), 26.04.2024
Tilføjet 26.04.2024
This report describes the sensitivity of different kinds of tests that detect SARS-CoV-2, the virus that causes COVID-19.
Læs mere
19
Use of Ebola Vaccines - Worldwide, 2021-2023
Morbidity and Mortality Weekly Report (MMWR), 26.04.2024
Tilføjet 26.04.2024
This report describes repurposing Ebola vaccines in the absence of large outbreaks.
Læs mere
20
Malariavacciner er et lille lyspunkt i en dyster udvikling
Statens Serum Institut, 25.04.2024
Tilføjet 25.04.2024
Bekæmpelsen af malaria er i de senere år gået den forkerte vej. Det skyldes blandt andet øget resistens, følger af covid-19-pandemien, de globale klimaforandringer og faldende finansiering til malariabekæmpelse. Introduktionen af de første malariavacciner i mange afrikanske lande i 2024 er et lille lyspunkt.
Læs mere
21
Electronic System Slashes Antibiotic Use
Medscape Infectious Diseases, 24.04.2024
Tilføjet 24.04.2024
Prescriptions for broad-spectrum antibiotics fell when clinicians were intercepted by a risk-assessment prompt. Medscape Medical News
Læs mere
22
Vaccine Safety and DMT for Highly Active MS: New Data
Medscape Infectious Diseases, 24.04.2024
Tilføjet 24.04.2024
Many clinicians delay CD20 treatment until vaccine schedules are complete. A study suggests that this precaution may not be necessary. Medscape Medical News
Læs mere
23
Long COVID Rates Elevated in Men With Type 2 Diabetes
Medscape Infectious Diseases, 24.04.2024
Tilføjet 24.04.2024
The opposite was seen in women when compared with matched control individuals without diabetes. Medscape UK
Læs mere
24
Congo Republic Declares Mpox Epidemic
Medscape Infectious Diseases, 24.04.2024
Tilføjet 24.04.2024
Republic of the Congo has declared an epidemic of mpox after 19 cases were confirmed across five departments, including the capital Brazzaville. Reuters Health Information
Læs mere
25
US FDA Says Commercial Milk Safe Despite Bird Flu Virus Presence
Medscape Infectious Diseases, 24.04.2024
Tilføjet 24.04.2024
The U.S. Food and Drug Administration said on Tuesday that it had found bird flu virus particles in some samples of pasteurized milk, but said commercial milk supply remains... Reuters Health Information
Læs mere
26
Can D-Mannose Prevent Recurrent Urinary Tract Infection?
Medscape Infectious Diseases, 24.04.2024
Tilføjet 24.04.2024
The global rise in antibiotic resistance has complicated the therapeutic choices for urinary tract infections. Medscape Medical News
Læs mere
27
Hepatitis Kills 3.5 Million People Each Day, Says WHO
Medscape Infectious Diseases, 24.04.2024
Tilføjet 24.04.2024
Although annual incidence decreased from 2.5 million in 2019 to 2.2 million in 2022, the WHO considers it to be high. Medscape Medical News
Læs mere
28
Opportunistic AI for Medical Scans
Medscape Infectious Diseases, 24.04.2024
Tilføjet 24.04.2024
A remarkable wealth of data are being missed. Medscape
Læs mere
29
Vaccine-Preventable Diseases Surge: Europe Sounds the Alarm
Medscape Infectious Diseases, 23.04.2024
Tilføjet 23.04.2024
ECDC data show that measles and pertussis cases are on the rise again after a post–COVID-19 pandemic decline. Medscape Medical News
Læs mere
30
Danske børn bliver i høj grad vaccineret
Statens Serum Institut, 22.04.2024
Tilføjet 22.04.2024
Ny rapport viser, at tilslutningen til det danske børnevaccinationsprogram fortsat er høj og stabil, men der er stadig lidt at hente, før vi lever helt op til målsætningerne for alle vacciner. HPV-vaccinen har den laveste tilslutning blandt børnevaccinerne.
Læs mere
31
Communicable disease threats report, 14-20 April 2024, week 16
ECDC
ECDC Communicable Disease Threats Report, 20.04.2024
Tilføjet 20.04.2024
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 14-20 April 2024 and includes updates on parvovirus B19 detections, cholera, chikungunya, dengue and poliomyelitis.
Læs mere